We are monitoring the impact of COVID-19 & Recession alarm on APAC Spine Biologics Market Get in touch with us for detailed analysis Know More

Know More

Share on

Asia Pacific Spine Biologics Market Research Report - Segmented By Product Type, Surgery Type & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 4121
Pages: 130

Asia Pacific Spine Biologics Market Size & Growth (2022 to 2027)

As per the research report, the size of the Asia Pacific Spine Biologics Market is valued at USD 472.05 million in 2022 and estimated to be growing at a CAGR of 4.9%, to reach USD 599.61 million by 2027 during the forecast period 2022 to 2027.

The Asia Pacific spine biologics market is primarily growing due to an increase in the number of occurrences of spine-related health conditions.

Spinal problems are affecting an increasing number of people across the continent. The Asia Pacific spine biologics market is expected to increase significantly as the population over 60 years old becomes more prone to spine issues and undergoes fusion procedures as a treatment. According to a study published in the Annals of Rheumatic Diseases, one out of ten adults suffers from lower back pain (LBP). According to research published by the World Health Organization (WHO) in 2013, between 250,000 and 300,000 people worldwide suffer from spinal cord injuries, with most of the injuries occurring due to traffic accidents, violence, and other falls.

Furthermore, the increased prevalence of obesity is a crucial driver of market growth. According to WHO projections, 1.9 billion persons were overweight in 2019, with 650 million obese. Growing healthcare spending and technological advancements are propelling the industry forward. In addition, the rising number of minimally invasive spine procedures is predicted to boost the Asia Pacific spine biologics market's growth rate. These factors are expected to drive this market forward during the forecast period.

The Asia Pacific spine biologics industry is being held back by high costs associated with spinal surgery and unfavorable reimbursement rules from various governments.

The government's strict laws & regulations in authorizing new products and their debut in people's safety are challenges for key stakeholders. In addition, to a small extent, a lack of thorough awareness about spine biologics and treatment processes obstructs market expansion.

During the projection period, the Asia Pacific Spine Biologics market would be restrained by a lack of proper healthcare infrastructure in some developing nations. Therefore, these factors are predicted to hinder the Asia Pacific Spine Biologics market during the forecast period.

Spinal disorders impact a growing number of people due to developments in spine surgery technologies. As a result, the Asia-Pacific market for spinal biologics is quickly growing. The sector is also benefiting from the desire for minimally invasive surgical techniques.

This research report on the APAC Spine Biologics Market has been segmented and sub-segmented into the following categories.

By Product Type:

  • platelet Rich Plasma
  • Bone Graft
  • Bone Graft Substitutes
  • Bone Marrow Aspirate Therapy

By Surgery Type:

  • Transforaminal Lumbar Interbody Fusion
  • Anterior Lumbar Interbody Fusion
  • Lateral Lumbar Interbody Fusion
  • Anterior Cervical Discectomy And Fusion
  • Posterior Lumbar Interbody Fusion
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia Pacific Spine Biologics Market growth will be moderate, and the region will grow dramatically over the period. This is because the general, people are becoming more environmentally conscious. This is expected to increase faster in the countries where the population is growing. In addition, medical technology is also rapidly evolving in these areas.

The Indian Spine Biologics Market is expected to be the market leader in the APAC region due to the growing senior population, the rising occurrence of spine abnormalities, and technological breakthroughs in bone grafting techniques contributing to the market growth.

Furthermore, increased occurrences of degenerative spine disorders, a significant increase in treatment rates, and growing demand for minimally invasive procedures drive market expansion.

The China Spine Biologics Market is predicted to hold a significant share of the APAC region, following India because of the advancements in biomaterials and minimally invasive procedure method linked with lateral body fusion are an excellent approach for the treatment of spine diseases because this technique is safe, effective, quick to recover from, and causes less injury. In addition, it also boosts demand for spine biologics in the treatment of disc degeneration, sclerosis, and other spine-related conditions.

KEY MARKET PLAYERS

Top companies dominating the APAC Spine Biologics Market profiled in the report are Depuy Synthes (Johnson & Johnson), Alphatec Holdings, Inc., Orthofix International N.V., RTI Surgical, Inc., SeaSpine, and Zimmer Biomet Holdings, Inc, Exactech, Inc., Globus Medical, Inc., Medtronic plc, NuVasive, Inc.,

1. Introduction   

                1.1 Market Definition     

                1.2 Study Deliverables   

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions 

2. Research Methodology             

                2.1 Introduction 

                2.2 Research Phases       

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design          

                2.4 Study Timeline           

3. Overview         

                3.1 Executive Summary 

                3.2 Key Inferences          

                3.3 Epidemology

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)      

                4.1 Market Drivers           

                4.2 Market Restraints     

                4.3 Key Challenges          

                4.4 Current Opportunities in the Market

5. Market Segmentation                

                5.1 Surgery type

                                5.1.1 Introduction                                           

                                5.1.2 Anterior Cervical Discectomy and Fusion                                   

                                5.1.3 Posterior Lumbar Interbody Fusion                                              

                                5.1.4 Transforaminal Lumbar Interbody Fusion                                  

                                5.1.5 Anterior Lumbar Interbody Fusion                               

                                5.1.6 Lateral Lumbar Interbody Fusion                                   

                                5.1.7 Others                                      

                                5.1.8  Y-o-Y Growth Analysis, By surgery type                                     

                                5.1.9  Market Attractiveness Analysis, By surgery type                                   

                                5.1.10 Market Share Analysis, By surgery type                                   

                5.2 Product type

                                5.2.1 Introduction                                           

                                5.2.2 Bone graft

5.2.2.1 Autograft                             

5.2.2.2 Allograft               

                                5.2.3 Bone graft substitutes                                       

5.2.3.1 Synthetic bone grafts                     

5.2.3.2 Demineralized bone matrix                          

5.2.3.3 Bone Morphogenetic proteins                   

                                5.2.4 Platelet rich plasma                                             

                                5.2.5 Bone marrow aspitaye therapy                                      

                                5.2.6 Y-o-Y Growth Analysis, By Product type                                     

                                5.2.7 Market Attractiveness Analysis, By Product type                                   

                                5.2.8 Market Share Analysis, By Product type                                     

6. Geographical Analysis                

                6.1 Introduction 

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

6.1.3.1 By Geographical Area                     

6.1.3.2 By Surgery type                 

6.1.3.3 By Product Type                

                                6.1.4  Market Attractiveness Analysis                                     

6.1.4.1 By Geographical Area                     

6.1.4.2 By Surgery type                 

6.1.4.3 By Product Type                

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Surgery type                 

6.1.5.3 By Product Type                

                6.2 China              

                6.3 India               

                6.4 Japan             

                6.5 South Korea 

                6.6 Australia       

7. Strategic Analysis         

                7.1 PESTLE analysis          

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis          

                8.1  Alphatec Holdings Inc.           

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Depuy Synthes          

                8.3 Exactech Inc.

                8.4 Globus Medical Inc. 

                8.5 Medtronic plc.            

                8.6 NuVasive Inc.             

                8.7 Orthofix International N.V.   

                8.8 RTI Surgical Inc.          

                8.9 SeaSpine      

                8.10 Zimmer Biomet Holdings Inc.             

9. Competitive Landscape             

                9.1 Market share analysis             

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10. Market Outlook and Investment Opportunities           

Appendix             

                a) List of Tables 

                b) List of Figures

  1. Asia Pacific Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  2. Asia Pacific Anterior Cervical Discectomy and Fusion Market By Region, From 2022 to 2027 ( USD Million )
  3. Asia Pacific Posterior Lumbar Interbody Fusion Market By Region, From 2022 to 2027 ( USD Million )
  4. Asia Pacific Transforaminal Lumbar Interbody Fusion Market By Region, From 2022 to 2027 ( USD Million )
  5. Asia Pacific Anterior Lumbar Interbody Fusion Market By Region, From 2022 to 2027 ( USD Million )
  6. Asia Pacific Lateral Lumbar Interbody Fusion Market By Region, From 2022 to 2027 ( USD Million )
  7. Asia Pacific Others Market By Region, From 2022 to 2027 ( USD Million )
  8. Asia Pacific Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  9. Asia Pacific Bone graft Market By Region, From 2022 to 2027 ( USD Million )
  10. Asia Pacific Bone graft substitutes Market By Region, From 2022 to 2027 ( USD Million )
  11. Asia Pacific Platelet rich plasma Market By Region, From 2022 to 2027 ( USD Million )
  12. Asia Pacific Bone marrow aspirate therapy Market By Region, From 2022 to 2027 ( USD Million )
  13. Japan Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  14. Japan Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  15. China Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  16. China Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  17. India Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  18. India Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  19. Australia Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  20. Australia Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  21. South Korea Spine Biologics Market By Surgery type, From 2022 to 2027 ( USD Million )
  22. South Korea Spine Biologics Market By Product type, From 2022 to 2027 ( USD Million )
  23. Asia Pacific Spine Biologics Market By Bone graft, From 2022 to 2027 ( USD Million )
  24. Asia Pacific Allograft Market By Region, From 2022 to 2027 ( USD Million )
  25. Asia Pacific Autograft Market By Region, From 2022 to 2027 ( USD Million )
  26. Japan Spine Biologics Market By Bone graft, From 2022 to 2027 ( USD Million )
  27. China Spine Biologics Market By Bone graft, From 2022 to 2027 ( USD Million )
  28. India Spine Biologics Market By Bone graft, From 2022 to 2027 ( USD Million )
  29. Australia Spine Biologics Market By Bone graft, From 2022 to 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample